FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: In LAMA-84 CML cells resistant to 0.5 or 2 μM imatinib, FN1 mRNA expression was not significantly deregulated, whereas in NALM-20 Ph + ALL cells, FN1 was undetectable (Supplementary Figure S1).